Profound Medical (PROF) Net Margin (2024 - 2026)

Profound Medical's Net Margin history runs 3 years deep, the most recent figure standing at 132.15% for Q1 2026.

• On a quarterly basis, Net Margin fell 27700.0% year-over-year to 132.15% in Q1 2026; TTM through Mar 2026 was 324.72%, a 4877.0% decrease from a year earlier, with the FY2025 full-year figure at 264.44%, up 399.0% from the prior year.
• Net Margin fell to 132.15% in Q1 2026 per PROF's latest filing, from 1287.69% in the prior quarter.
• Across five years, Net Margin topped out at 1287.69% in Q4 2025 and bottomed at 709.86% in Q2 2025.
• The 3-year median for Net Margin is 157.68% (2025), against an average of 79.91%.
• Biggest YoY gain for Net Margin was 94935 bps in 2025; the steepest drop was 35558 bps in 2025.
• Year by year, Net Margin stood at 1020.64% in 2024, then gained by 26 bps to 1287.69% in 2025, then slumped by 90 bps to 132.15% in 2026.
• Per Business Quant, the three latest PROF Net Margin figures stand at 132.15% (Q1 2026), 1287.69% (Q4 2025), and 157.68% (Q3 2025).